Gd-EOB-DTPA-enhanced magnetic resonance imaging findings of nondiffuse fatty change of the liver

Journal of Computer Assisted Tomography

Volumn 34, Issue 6, 2010, Pages 868-873

  Yamamoto, Akira ^a   Tamada, Tsutomu ^a   Sone, Teruki ^a   Higashi, Hiroki ^a   Yamashita, Takenori ^a   Ito, Katsuyoshi ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

contrast agent; Gd EOB DTPA; liver; magnetic resonance imaging; nondiffuse fatty change

Indexed keywords

FATTY ACIDS; IMAGE ENHANCEMENT; MAGNETISM; RESONANCE;

ALL PHASE; CONTRAST AGENT; DIETHYLENETRIAMINE PENTA-ACETIC ACIDS; DYNAMIC CONTRAST-ENHANCED; DYNAMIC STUDIES; ENHANCEMENT EFFECTS; GADOLINIA; GADOLINIA-ETHOXYBENZYL-DIETHYLENETRIAMINE PENTAACETIC ACID; NONDIFFUSE FATTY CHANGE; SIGNAL ENHANCEMENT;

MAGNETIC RESONANCE IMAGING;

GADOXETIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; FATTY LIVER; FEMALE; HUMAN; IMAGE ENHANCEMENT; MALE; MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 78650477214     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/RCT.0b013e3181ef1db1     Document Type: Article

References (31)

1. Scott WW, Sanders RC, Siegelman SS. Irregular fatty infiltration of the liver: Diagnostic dilemmas. AJR Am J Roentgenol. 1980;135:67-71.
2. Halvorsen RA, Korobkin M, Ram PC, et al. CT appearance of focal fatty infiltration of the liver. AJR Am J Roentgenol. 1982;139:277-281.
3. Baker MK, Wenker JC, Cockerill EM, et al. Focal fatty infiltration of the liver: Diagnostic imaging. Radiographics. 1985;5:923-929.
4. Doyle FH, Pennock JM, Banks LM, et al. Nuclear magnetic resonance imaging of the liver: Initial experience. AJR Am J Roentgenol. 1982; 138:193-200.
5. Mitchell DG. Focal manifestations of diffuse liver disease at MR imaging. Radiology. 1992;185:1-11.
6. Paulson EK, Baker ME, Spritzer CE, et al. Focal fatty infiltration: A cause of nontumorous defects in the left hepatic lobe during CT arterial portography. J Comput Assist Tomogr. 1993;17:590-595.
7. Ito K, Choji T, Nakada T, et al. Multislice dynamic MRI of hepatic tumors. J Comput Assist Tomogr. 1993;17:390-396.
8. de Lange EE, Mugler JP 3rd, Gay SB, et al. Focal liver disease: Comparison of breath-hold T1-weighted MP-GRE MR imaging and contrast-enhanced CTVlesion detection, localization, and characterization. Radiology. 1996;200:465-473.
9. Semelka RC, Martin DR, Balci C, et al. Focal liver lesions: Comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement. J Magn Reson Imaging. 2001;13:397-401.
10. Bilgili Y, Firat Z, Pamuklar E, et al. Focal liver lesions evaluated by MR imaging. Diagn Interv Radiol. 2006;12:129-135.
11. Weinmann HJ, Schuhmann-Giampieri G, Schmitt-Willich H, et al. A new lipophilic gadolinium chelate as a tissue-specific contrast medium for MRI. Magn Reson Med. 1991;22:233-237.
12. Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, et al. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology. 1992;183:59-64.
13. Vogl TJ, Kümmel S, Hammerstingl R, et al. Liver tumors: Comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology. 1996;200:59-67.
14. Reimer P, Rummeny EJ, Daldrup HE, et al. Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: Preliminary results with dynamic MR imaging. Eur Radiol. 1997;7:275-280.
15. Huppertz A, Balzer T, Blakeborough A, et al. Improved detection of focal liver lesions at MR imaging: Multicenter comparison of gadoxetic acidYenhanced MR images with intraoperative findings. Radiology. 2004;230:266-275.
16. Wehrli FW, Perkins TG, Shimakawa A, et al. Chemical shiftYinduced amplitude modulations in images obtained with gradient refocusing. Magn Reson Imaging. 1987;5:157-158.
17. Mitchell DG, Kim I, Chang TS, et al. Fatty liver: Chemical shift phase-difference and suppression magnetic resonance imaging techniques in animals, phantoms, and humans. Invest Radiol. 1991;26:1041-1052.
18. Fishbein MH, Gardner KG, Potter CJ, et al. Introduction of fast MR imaging in the assessment of hepatic steatosis. Magn Reson Imaging. 1997;15:287-293.
19. Martín J, Puig J, Falcó J, et al. Hyperechoic liver nodules: Characterization with proton fat-water chemical shift MR imaging. Radiology. 1998;207:325-330.
20. Yoshikawa J, Matsui O, Takashima T, et al. Focal fatty change of the liver adjacent to the falciform ligament: CT and sonographic findings in five surgically confirmed cases. AJR Am J Roentgenol. 1987;149: 491-494.
21. Kawashima A, Suehiro S, Murayama S, et al. Focal fatty infiltration of the liver mimicking a tumor: Sonographic and CT features. J Comput Assist Tomogr. 1986;10:329-331.
22. Chong VFH, Fan YF. Ultrasonographic hepatic pseudolesions: Normal parenchyma mimicking mass lesions in fatty liver. Clin Radiol. 1994;49:326-329.
23. Kreft BP, Tanimoto A, Baba Y, et al. Diagnosis of fatty liver with MR imaging. J Magn Reson Imaging. 1992;2:463-471.
24. Hirohashi S, Ueda, K, Uchida H, et al. Nondiffuse fatty change of the liver: Discerning pseudotumor on MR images enhanced with ferumoxidesVinitial observations. Radiology. 2000;217: 415-420.
25. Weissleder R. Liver MR imaging with iron oxides: Toward consensus and clinical practice [editorial]. Radiology. 1994;193:593-595.
26. Winter TC 3rd, Freeny PC, Nghiem HV, et al. MR imaging with i.v. superparamagnetic iron oxide: Efficacy in the detection of focal hepatic lesions. AJR Am J Roentgenol. 1993;161: 1191-1198.
27. Vogl TJ, Hammerstingl R, Schwarz W, et al. Superparamagnetic iron oxideYenhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. Radiology. 1996;198: 881-887.
28. Kuwatsuru R, Brasch RC, Mühler A, et al. Definition of liver tumors in the presence of diffuse liver disease: Comparison of findings at MR imaging with positive and negative contrast agents. Radiology. 1997;202:131-138.
29. Levenson H, Greensite F, Hoefs J, et al. Fatty infiltration of the liver: Quantification with phase-contrast MR imaging at 1.5 T vs biopsy. AJR Am J Roentgenol. 1991;156:307-312.
30. Merkle EM, Nelson RC. Dual gradient-echo in-phase and opposed- phase hepatic MR imaging: A useful tool for evaluating more than fatty infiltration or fatty sparing. Radiographics. 2006;26: 1409-1418.
31. Tsuda N, Okada M, Murakami T. Potential of gadolinium-ethoxybenzyl- diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) for differential diagnosis of nonalcoholic steatohepatitis and fatty liver in rats using magnetic resonance imaging. Invest Radiol. 2007;42:242-247.